COMMUNIQUÉS West-GlobeNewswire

GENFIT ANNONCE SON INTENTION DE PROCÉDER À UNE OFFRE AU PUBLIC AUX ÉTATS-UNIS

19/11/2018 - 07:49

POUR DIFFUSION IMMÉDIATE GENFIT ANNONCE SON INTENTION DE PROCÉDER À UNE OFFRE AU PUBLIC AUX ÉTATS-UNIS Lille (France), Cambridge (Massachusetts, États-Unis), le 19 novembre 2018 - GENFIT SA (Euronext : GNFT), une [...]

Sonoma Pharmaceuticals Announces Pricing of Public Offering of Units

17/11/2018 - 17:01

PETALUMA, Calif., Nov. 17, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) today announced the pricing of a “best efforts” public offering of units consisting of one share of common stock, together [...]

Teligent, Inc. Receives Notification of Deficiency From NASDAQ Related to the Delayed Filing of Form 10-Q

16/11/2018 - 23:15

BUENA, N.J., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), on November 13, 2018 received a standard notice from NASDAQ stating that, as a result of not having timely filed its quarterly report on Form [...]

FDA approves Novartis drug Promacta® for first-line SAA and grants Breakthrough Therapy designation for additional new indication

16/11/2018 - 22:31

Promacta receives FDA approval for first-line treatment of severe aplastic anemia (SAA) and Breakthrough Therapy designation for low platelet counts in people exposed to radiation Approval based on compelling benefit [...]

CareDx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

16/11/2018 - 22:01

BRISBANE, Calif., Nov. 16, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]

Ziopharm Oncology Provides Controlled IL-12 Update with Positive Data from Phase 1 Trial Presented at Annual Meeting of the Society for Neuro-Oncology

16/11/2018 - 20:30

Ad-RTS-hIL-12 plus 20mg veledimex (Controlled IL-12) determined to be preferred dosing with low-dose steroids to treat adult patients with recurrent glioblastoma Median overall survival for Ad-RTS-hIL-12 plus veledimex [...]

Golden Leaf Closes C$7.9 million Private Placement of Unsecured Convertible Subordinated Debenture Units

16/11/2018 - 16:25

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 16, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (the “Company”, “Golden Leaf” or the “Issuer”) (CSE: [...]

Letter to Shareholders to accompany recent proxy filing

16/11/2018 - 15:32

CEO to share a few thoughts in advance of the upcoming shareholder call on Monday, November 19 th at 5PM EST NEW HAVEN, Conn., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: [...]

Flexion Therapeutics Named Top Place to Work for Second Consecutive Year by The Boston Globe

16/11/2018 - 15:22

BURLINGTON, Mass., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has been named one of the Top Places to Work in Massachusetts for the second consecutive year. The [...]

New Findings Presented at the VEITHsymposium Reiterate Consistent, Durable Outcomes in Complex Aortic Disease with Heli-FX(TM) Endoanchor(TM) System

16/11/2018 - 15:01

Three-Year Data from the ANCHOR Registry Reiterate Applicability in Patients with Hostile Aortic Neck Anatomies DUBLIN and NEW YORK - November 16, 2018 - Medtronic plc (NYSE:MDT) today announced new data on the Heli-FX( [...]

ATW Tech Provides Additional Information Regarding Signature of a Letter of Intent for Major Acquisition of Greywolf Entertainment Group

16/11/2018 - 15:00

MONTREAL, Nov. 16, 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (“ ATW Tech ”) (TSX-V: ATW) has, as previously announced on November 6, 2018, signed a letter of intent for the acquisition from Fastrack Trust (the “ Trust ”) [...]

ATW Tech fournit de l’information additionnelle sur la signature de la lettre d’intention pour l’acquisition majeure du Groupe Greywolf Entertainement

16/11/2018 - 15:00

MONTRÉAL, 16 nov. 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (« ATW Tech ») ( TSX-V : ATW ), a signé, tel qu’annoncé le 6 novembre 2018, une lettre d’intention visant l’acquisition de la totalité des actions de 6855318 [...]

Lifestyle Brand Weekend Unlimited Expanding Into Key US, Foreign Markets -- CFN Media

16/11/2018 - 15:00

SEATTLE, Nov. 16, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Menlo Therapeutics to Participate in the 30th Annual Piper Jaffray Healthcare Conference

16/11/2018 - 14:30

REDWOOD CITY, Calif., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus associated [...]

Aurora Spine Announces Exclusive Patent License Agreement for MIS SI Joint Product

16/11/2018 - 14:30

CARLSBAD, Calif., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (TSXV:ASG) ("Aurora Spine" or the "Company") announced today that it has acquired an exclusive license to US patent #9,451,986 titled “ [...]

Dragon Jade Announces Filing of Registration Statement for Proposed Registered Offering

16/11/2018 - 14:30

HONG KONG, Nov. 16, 2018 (GLOBE NEWSWIRE) -- Dragon Jade International Limited (“Dragon Jade” or “the Company”) (OTCQX: DGJI), a provider of premier products and services, today notes that it has filed a registration [...]

Novartis receives positive CHMP opinion to expand Kisqali® combination therapy to all women with HR+/HER2- locally advanced or metastatic breast cancer

16/11/2018 - 14:10

Kisqali is the CDK4/6 inhibitor with the largest body of first-line evidence demonstrating consistent, superior and sustained efficacy vs. endocrine therapy alone[1] CHMP opinion is supported by two pivotal Phase III [...]

Progressive Care Inc. Announces Record-Breaking October 2018

16/11/2018 - 14:00

MIAMI, Nov. 16, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and record-breaking [...]

Neon Therapeutics Named a Top Place to Work in Massachusetts by The Boston Globe

16/11/2018 - 14:00

CAMBRIDGE, Mass., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics (Nasdaq: NTGN) has been named one of the top places to work in Massachusetts by The Boston Globe , an honor awarded based on employee feedback. The [...]